24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Nucleai
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
11:46
Bank Leumi CEO: "The state is not doing enough to realize the upside after the attack on Iran"
11:02
Sky high: El Al’s CEO rakes in $9M in just three years on the job
10:30
I’m not willing to give up hope
09:58
Notable Capital expands Israeli operations with Eliya Elon on board
More stories
Buzz
Most popular
Daily
Weekly
1
Island raises tens of millions from J.P. Morgan at $4.8B valuation
2
Remote work’s dark side: The Soham Parekh story
3
High-tech’s hidden unemployment crisis: Veteran workers hit hard
4
How ChatGPT pinpointed Iranian missile strikes with just Google and the news
5
‘This is the real long COVID’: Remote jobs, fake resumes and Soham Parekh
More news
Nucleai
6 stories about Nucleai
Spatial AI biomarker startup Nucleai raises $14 million led by Merck’s VC arm
03.04.24
|
CTech
Leveraging AI and machine learning, Nucleai analyzes pathology images and spatial data at the cellular and tissue levels. The proprietary technology extracts detailed patterns and features from medical images, offering insights into the tumor microenvironment, cellular morphology, and spatial relationships between different cell types
How have international stakeholders responded to Startup Nation since 7/10?
26.10.23
|
James Spiro
Nucleai helped its global customers and investors understand the magnitude of October 7 by comparing it to 9/11 in the U.S.
Nucleai raises $33 million for spatial biology drug development platform
22.03.22
|
Meir Orbach
The technology developed at the Israeli startup allows better prediction of the patient's response to specific oncological treatment, saves on the ongoing process of testing different drugs and improves the chances of the development of new cancer drugs
The Israeli startup using spatial biology to provide better cancer treatment
02.01.22
|
Yafit Ovadia
Nucleai is looking at the way cells interplay and are interspersed within human tissue to develop precision medicine solutions
AI cancer treatment startup Nucleai raises $6.5 million in series A round
07.07.20
|
Meir Orbach
Nucleai’s software uses computer vision and machine learning algorithms to predict the progress of cancerous tumors as well as the patient’s immune system response in order to determine the most efficient treatment
CTech’s Monday Israeli Tech News Roundup
05.03.18
|
CTech
Israel wants to lure U.S. scientists with $100 thousand grants. Barclays ends partnership with Ness Technologies